Medical Developments International (M5D) Stock Overview

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. More details

M5D fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 96.2% below our estimate of its fair value

Earnings are forecast to grow 79.99% per year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (€28M)

M5D Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Medical Developments International Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medical Developments International
Historical stock prices
Current Share Price	AU$0.21
52 Week High	AU$0.32
52 Week Low	AU$0.01
Beta	1.38
1 Month Change	-25.36%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	9.57%

Recent updates

Shareholder Returns

	M5D	DE Pharmaceuticals	DE Market
7D	-8.8%	6.1%	3.2%
1Y	n/a	27.3%	2.5%

Return vs Industry: Insufficient data to determine how M5D performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how M5D performed against the German Market.

Price Volatility

Is M5D's price volatile compared to industry and market?
M5D volatility
M5D Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.4%
Market Average Movement	6.1%
10% most volatile stocks in DE Market	13.3%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: M5D's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine M5D's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1972	n/a	Brent MacGregor	medicaldev.com

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.

Medical Developments International Limited Fundamentals Summary

How do Medical Developments International's earnings and revenue compare to its market cap?
M5D fundamental statistics
Market cap	€28.38m
Earnings (TTM)	-€267.92k
Revenue (TTM)	€24.97m

1.1x

P/S Ratio

-105.9x

P/E Ratio

Is M5D overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M5D income statement (TTM)
Revenue	AU$40.64m
Cost of Revenue	AU$10.08m
Gross Profit	AU$30.56m
Other Expenses	AU$30.99m
Earnings	-AU$436.00k

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0039
Gross Margin	75.19%
Net Profit Margin	-1.07%
Debt/Equity Ratio	0%

How did M5D perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/24 11:10
End of Day Share Price	2026/05/22 00:00
Earnings	2025/12/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medical Developments International Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Martyn Jacobs	Bell Potter
Martyn Jacobs	Canaccord Genuity
Dan Hurren	MST Financial Services Pty Limited

Medical Developments International LimitedDB:M5D Stock Report